References
- Fujimaki K., Noumi T., Saikawa I., Inoue M., Mitsuhashi S. In vitro and in vivo activity of T-3262, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy 1988; 32: 827–833
- Kojima T., Inoue M., Mitsuhashi S. In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrobial Agents and Chemotherapy 1989; 33: 1980–1988
- Lode H., Höffken G., Olschewski P., Sievers B., Kirch A., Borner K., Koeppe P. Pharmacokinetics of ofloxacin after parental and oral administration. Antimicrobial Agents and Chemotherapy 1987; 31: 1338–1342
- Sato K., Matsuura Y., Inoue M., Une T., Osada Y., Ogawa H., Mitsuhashi S. In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrobial Agents and Chemotherapy 1982; 22: 548–553
- Swanson B. N., Boppana V. K., Vlasses P. H., Rotmensch H. H., Ferguson R. K. Norfloxacin disposition after sequentially increasing oral doses. Antimicrobial Agents and Chemotherapy 1983; 23: 284–288
- Tanaka M., Hoshino K., Ishida H., Sato K., Hayakawa I., Osada Y. Antimicrobial activity of DV-7751a, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy 1993; 37: 2112–2118
- Tanaka M., Oshima Y., Aoki H., Hakusui H. Determination of a new fluoroquinolone antimicrobial agent, (S)-10-[(S)-(8-amino-6-azaspiro[3, 4]octan—6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1, 2, 3-de][1, 4]benzoxazine-6-carboxylic acid hemihydrate, DV- 7751a, in human serum and urine using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. Journal of Chromatography 1995; 664: 401–407
- Tartaglione T. A., Raffalovich A. C., Poyner W. J., Espinel-Ingroff A., Kerkering T. M. Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses. Anitmicrobial Agents and Chemotherapy 1986; 29: 62–66
- Thorsteinsson S. B., Bergan T., Oddsdottir S., Rohwedder R., Hohm R. Crystalluria and ciprofloxacin, influence of urinary pH and hydration. Chemotherapy 1986; 32: 408–417
- Wise R., Andrews J. M., Edwards L. J. In vitro activity of Bay 09867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983; 23: 559–564